Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Advanced Therapies, Genetic Therapy collaborate on gene therapy

Aug. 16, 1996

Kyorin, Sagami report antineoplastic acrylamides

Aug. 16, 1996

Pola claims antisense oligonucleotides for cancer

Aug. 16, 1996

Mitsui Toatsu claims potential antitumor agents

Aug. 16, 1996

GEM-230 in preclinical testing at Hybridon

Aug. 16, 1996

ISIS-3521/CGP-64128A efficacy shown in preclinical models

Aug. 16, 1996

MAM-102: antineoplastic protein tyrosine kinase inhibitor

Aug. 16, 1996

Letrozole approved for marketing in France

Aug. 16, 1996

Sanofi Winthrop discloses topoisomerase II inhibitors

Aug. 16, 1996

Guilford to develop anticancer drugs in biodegradable polymers

Aug. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026
SERCA inhibitor shows promise for MSA-C treatment
BioWorld Science
At the ongoing International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD 2026) in Copenhagen, researchers...